APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Similar Biological Medicinal Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Similar Biological Medicinal Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchSimilar Biological Medicinal Products Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Similar Biological Medicinal Products Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Similar Biological Medicinal Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Similar Biological Medicinal Products Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Similar Biological Medicinal Products Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Similar Biological Medicinal Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Similar Biological Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Similar Biological Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Similar Biological Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Similar Biological Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Similar Biological Medicinal Products include CITIC Guojian, Changchun High-tech, Innovent Biologics, Saijin Biotechnology, Fuhong Hanlin, Baitai Biology, Biotech, Sandoz and Samsung Bioepies Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Similar Biological Medicinal Products output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Similar Biological Medicinal Products by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Similar Biological Medicinal Products market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Similar Biological Medicinal Products and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Similar Biological Medicinal Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Similar Biological Medicinal Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Similar Biological Medicinal Products Segment by Company

CITIC Guojian

Changchun High-tech

Innovent Biologics

Saijin Biotechnology

Fuhong Hanlin

Baitai Biology

Biotech

Sandoz

Samsung Bioepies Co., Ltd

Amgen

Celltrion Healthcare

Coherus Biosciences, Inc.

Eli Lilly

Novartis AG

Pfizer Inc

Stada Arzneimittel AG

Teva Pharmaceutical Industries Ltd

Viatris

Similar Biological Medicinal Products Segment by Type

Monoclonal Antibodies

Anti-inflammatory Drugs

Immunomodulator

Recombinant Hormone

Others

Similar Biological Medicinal Products Segment by Application

Oncology

Blood Disorders

Growth Hormone Deficiency

Chronic and Autoimmune Diseases

Others

Similar Biological Medicinal Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Similar Biological Medicinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Similar Biological Medicinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Similar Biological Medicinal Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Similar Biological Medicinal Products market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Similar Biological Medicinal Products industry.

Chapter 3: Detailed analysis of Similar Biological Medicinal Products market competition landscape. Including Similar Biological Medicinal Products manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Similar Biological Medicinal Products by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Similar Biological Medicinal Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Similar Biological Medicinal Products Industry Trends Table 2. Similar Biological Medicinal Products Industry Drivers Table 3. Similar Biological Medicinal Products Industry Opportunities and Challenges Table 4. Similar Biological Medicinal Products Industry Restraints Table 5. Global Similar Biological Medicinal Products Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Similar Biological Medicinal Products Production Value Share by Manufacturers (2021-2026) Table 7. Global Similar Biological Medicinal Products Production by Manufacturers (Tons) & (2021-2026) Table 8. Global Similar Biological Medicinal Products Production Market Share by Manufacturers Table 9. Global Similar Biological Medicinal Products Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Similar Biological Medicinal Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Similar Biological Medicinal Products Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Similar Biological Medicinal Products Manufacturers, Product Type & Application Table 13. Global Similar Biological Medicinal Products Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Similar Biological Medicinal Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Monoclonal Antibodies Table 17. Major Manufacturers of Anti-inflammatory Drugs Table 18. Major Manufacturers of Immunomodulator Table 19. Major Manufacturers of Recombinant Hormone Table 20. Major Manufacturers of Others Table 21. Global Similar Biological Medicinal Products Production by Type 2021 VS 2025 VS 2032 (Tons) Table 22. Global Similar Biological Medicinal Products Production by Type (2021-2026) & (Tons) Table 23. Global Similar Biological Medicinal Products Production by Type (2027-2032) & (Tons) Table 24. Global Similar Biological Medicinal Products Production Market Share by Type (2021-2026) Table 25. Global Similar Biological Medicinal Products Production Market Share by Type (2027-2032) Table 26. Global Similar Biological Medicinal Products Production Value by Type 2021 VS 2025 VS 2032 (Tons) Table 27. Global Similar Biological Medicinal Products Production Value by Type (2021-2026) & (Tons) Table 28. Global Similar Biological Medicinal Products Production Value by Type (2027-2032) & (Tons) Table 29. Global Similar Biological Medicinal Products Production Value Market Share by Type (2021-2026) Table 30. Global Similar Biological Medicinal Products Production Value Market Share by Type (2027-2032) Table 31. Major Manufacturers of Oncology Table 32. Major Manufacturers of Blood Disorders Table 33. Major Manufacturers of Growth Hormone Deficiency Table 34. Major Manufacturers of Chronic and Autoimmune Diseases Table 35. Major Manufacturers of Others Table 36. Global Similar Biological Medicinal Products Production by Application 2021 VS 2025 VS 2032 (Tons) Table 37. Global Similar Biological Medicinal Products Production by Application (2021-2026) & (Tons) Table 38. Global Similar Biological Medicinal Products Production by Application (2027-2032) & (Tons) Table 39. Global Similar Biological Medicinal Products Production Market Share by Application (2021-2026) Table 40. Global Similar Biological Medicinal Products Production Market Share by Application (2027-2032) Table 41. Global Similar Biological Medicinal Products Production Value by Application 2021 VS 2025 VS 2032 (Tons) Table 42. Global Similar Biological Medicinal Products Production Value by Application (2021-2026) & (Tons) Table 43. Global Similar Biological Medicinal Products Production Value by Application (2027-2032) & (Tons) Table 44. Global Similar Biological Medicinal Products Production Value Market Share by Application (2021-2026) Table 45. Global Similar Biological Medicinal Products Production Value Market Share by Application (2027-2032) Table 46. CITIC Guojian Company Information Table 47. CITIC Guojian Business Overview Table 48. CITIC Guojian Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 49. CITIC Guojian Similar Biological Medicinal Products Product Portfolio Table 50. CITIC Guojian Recent Development Table 51. Changchun High-tech Company Information Table 52. Changchun High-tech Business Overview Table 53. Changchun High-tech Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 54. Changchun High-tech Similar Biological Medicinal Products Product Portfolio Table 55. Changchun High-tech Recent Development Table 56. Innovent Biologics Company Information Table 57. Innovent Biologics Business Overview Table 58. Innovent Biologics Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 59. Innovent Biologics Similar Biological Medicinal Products Product Portfolio Table 60. Innovent Biologics Recent Development Table 61. Saijin Biotechnology Company Information Table 62. Saijin Biotechnology Business Overview Table 63. Saijin Biotechnology Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 64. Saijin Biotechnology Similar Biological Medicinal Products Product Portfolio Table 65. Saijin Biotechnology Recent Development Table 66. Fuhong Hanlin Company Information Table 67. Fuhong Hanlin Business Overview Table 68. Fuhong Hanlin Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. Fuhong Hanlin Similar Biological Medicinal Products Product Portfolio Table 70. Fuhong Hanlin Recent Development Table 71. Baitai Biology Company Information Table 72. Baitai Biology Business Overview Table 73. Baitai Biology Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Baitai Biology Similar Biological Medicinal Products Product Portfolio Table 75. Baitai Biology Recent Development Table 76. Biotech Company Information Table 77. Biotech Business Overview Table 78. Biotech Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Biotech Similar Biological Medicinal Products Product Portfolio Table 80. Biotech Recent Development Table 81. Sandoz Company Information Table 82. Sandoz Business Overview Table 83. Sandoz Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Sandoz Similar Biological Medicinal Products Product Portfolio Table 85. Sandoz Recent Development Table 86. Samsung Bioepies Co., Ltd Company Information Table 87. Samsung Bioepies Co., Ltd Business Overview Table 88. Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Product Portfolio Table 90. Samsung Bioepies Co., Ltd Recent Development Table 91. Amgen Company Information Table 92. Amgen Business Overview Table 93. Amgen Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Amgen Similar Biological Medicinal Products Product Portfolio Table 95. Amgen Recent Development Table 96. Celltrion Healthcare Company Information Table 97. Celltrion Healthcare Business Overview Table 98. Celltrion Healthcare Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Celltrion Healthcare Similar Biological Medicinal Products Product Portfolio Table 100. Celltrion Healthcare Recent Development Table 101. Coherus Biosciences, Inc. Company Information Table 102. Coherus Biosciences, Inc. Business Overview Table 103. Coherus Biosciences, Inc. Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Coherus Biosciences, Inc. Similar Biological Medicinal Products Product Portfolio Table 105. Coherus Biosciences, Inc. Recent Development Table 106. Eli Lilly Company Information Table 107. Eli Lilly Business Overview Table 108. Eli Lilly Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Eli Lilly Similar Biological Medicinal Products Product Portfolio Table 110. Eli Lilly Recent Development Table 111. Novartis AG Company Information Table 112. Novartis AG Business Overview Table 113. Novartis AG Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Novartis AG Similar Biological Medicinal Products Product Portfolio Table 115. Novartis AG Recent Development Table 116. Pfizer Inc Company Information Table 117. Pfizer Inc Business Overview Table 118. Pfizer Inc Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Pfizer Inc Similar Biological Medicinal Products Product Portfolio Table 120. Pfizer Inc Recent Development Table 121. Stada Arzneimittel AG Company Information Table 122. Stada Arzneimittel AG Business Overview Table 123. Stada Arzneimittel AG Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. Stada Arzneimittel AG Similar Biological Medicinal Products Product Portfolio Table 125. Stada Arzneimittel AG Recent Development Table 126. Teva Pharmaceutical Industries Ltd Company Information Table 127. Teva Pharmaceutical Industries Ltd Business Overview Table 128. Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 129. Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Product Portfolio Table 130. Teva Pharmaceutical Industries Ltd Recent Development Table 131. Viatris Company Information Table 132. Viatris Business Overview Table 133. Viatris Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 134. Viatris Similar Biological Medicinal Products Product Portfolio Table 135. Viatris Recent Development Table 136. Global Similar Biological Medicinal Products Production by Region: 2021 VS 2025 VS 2032 (Tons) Table 137. Global Similar Biological Medicinal Products Production by Region (2021-2026) & (Tons) Table 138. Global Similar Biological Medicinal Products Production Market Share by Region (2021-2026) Table 139. Global Similar Biological Medicinal Products Production Forecast by Region (2027-2032) & (Tons) Table 140. Global Similar Biological Medicinal Products Production Market Share Forecast by Region (2027-2032) Table 141. Global Similar Biological Medicinal Products Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 142. Global Similar Biological Medicinal Products Production Value by Region (2021-2026) & (US$ Million) Table 143. Global Similar Biological Medicinal Products Production Value Share by Region (2021-2026) Table 144. Global Similar Biological Medicinal Products Production Value by Region (2027-2032) & (US$ Million) Table 145. Global Similar Biological Medicinal Products Production Value Share by Region: (2027-2032) & (US$ Million) Table 146. Global Similar Biological Medicinal Products Market Average Price (US$/Ton) by Region (2021-2026) Table 147. Global Similar Biological Medicinal Products Market Average Price (US$/Ton) by Region (2027-2032) Table 148. Global Similar Biological Medicinal Products Consumption by Region: 2021 VS 2025 VS 2032 (Tons) Table 149. Global Similar Biological Medicinal Products Consumption by Region (2021-2026) & (Tons) Table 150. Global Similar Biological Medicinal Products Consumption Market Share by Region (2021-2026) Table 151. Global Similar Biological Medicinal Products Consumption Forecasted by Region (2027-2032) & (Tons) Table 152. Global Similar Biological Medicinal Products Consumption Forecasted Market Share by Region (2027-2032) Table 153. North America Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 154. North America Similar Biological Medicinal Products Consumption by Country (2021-2026) & (Tons) Table 155. North America Similar Biological Medicinal Products Consumption by Country (2027-2032) & (Tons) Table 156. Europe Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 157. Europe Similar Biological Medicinal Products Consumption by Country (2021-2026) & (Tons) Table 158. Europe Similar Biological Medicinal Products Consumption by Country (2027-2032) & (Tons) Table 159. Asia Pacific Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 160. Asia Pacific Similar Biological Medicinal Products Consumption by Country (2021-2026) & (Tons) Table 161. Asia Pacific Similar Biological Medicinal Products Consumption by Country (2027-2032) & (Tons) Table 162. South America Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 163. South America Similar Biological Medicinal Products Consumption by Country (2021-2026) & (Tons) Table 164. South America Similar Biological Medicinal Products Consumption by Country (2027-2032) & (Tons) Table 165. Middle East & Africa Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 166. Middle East & Africa Similar Biological Medicinal Products Consumption by Country (2021-2026) & (Tons) Table 167. Middle East & Africa Similar Biological Medicinal Products Consumption by Country (2027-2032) & (Tons) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Similar Biological Medicinal Products Distributors List Table 171. Similar Biological Medicinal Products Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Similar Biological Medicinal Products Product Image Figure 2. Global Similar Biological Medicinal Products Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Similar Biological Medicinal Products Production Value (2021-2032) & (US$ Million) Figure 4. Global Similar Biological Medicinal Products Production Capacity (2021-2032) & (Tons) Figure 5. Global Similar Biological Medicinal Products Production (2021-2032) & (Tons) Figure 6. Global Similar Biological Medicinal Products Average Price (US$/Ton) & (2021-2032) Figure 7. Global Top 5 and 10 Similar Biological Medicinal Products Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Monoclonal Antibodies Image Figure 10. Anti-inflammatory Drugs Image Figure 11. Immunomodulator Image Figure 12. Recombinant Hormone Image Figure 13. Others Image Figure 14. Global Similar Biological Medicinal Products Production by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Similar Biological Medicinal Products Production Market Share 2021 VS 2025 VS 2032 Figure 16. Global Similar Biological Medicinal Products Production Market Share by Type (2021-2032) Figure 17. Global Similar Biological Medicinal Products Production Value by Type (2021 VS 2025 VS 2032) & (Tons) Figure 18. Global Similar Biological Medicinal Products Production Value Share 2021 VS 2025 VS 2032 Figure 19. Global Similar Biological Medicinal Products Production Value Share by Type (2021-2032) Figure 20. Oncology Image Figure 21. Blood Disorders Image Figure 22. Growth Hormone Deficiency Image Figure 23. Chronic and Autoimmune Diseases Image Figure 24. Others Image Figure 25. Global Similar Biological Medicinal Products Production by Application (2021 VS 2025 VS 2032) & (Tons) Figure 26. Global Similar Biological Medicinal Products Production Market Share 2021 VS 2025 VS 2032 Figure 27. Global Similar Biological Medicinal Products Production Market Share by Application (2021-2032) Figure 28. Global Similar Biological Medicinal Products Production Value by Application (2021 VS 2025 VS 2032) & (Tons) Figure 29. Global Similar Biological Medicinal Products Production Value Share 2021 VS 2025 VS 2032 Figure 30. Global Similar Biological Medicinal Products Production Value Share by Application (2021-2032) Figure 31. Global Similar Biological Medicinal Products Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 32. Global Similar Biological Medicinal Products Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Similar Biological Medicinal Products Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Similar Biological Medicinal Products Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Similar Biological Medicinal Products Production Value (2021-2032) & (US$ Million) Figure 36. Europe Similar Biological Medicinal Products Production Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Similar Biological Medicinal Products Production Value (2021-2032) & (US$ Million) Figure 38. South America Similar Biological Medicinal Products Production Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Similar Biological Medicinal Products Production Value (2021-2032) & (US$ Million) Figure 40. North America Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. North America Similar Biological Medicinal Products Consumption Market Share by Country (2021-2032) Figure 42. U.S. Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 43. Canada Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. Mexico Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. Europe Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Europe Similar Biological Medicinal Products Consumption Market Share by Country (2021-2032) Figure 47. Germany Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. France Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 49. U.K. Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 50. Italy Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 51. Netherlands Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. Asia Pacific Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. Asia Pacific Similar Biological Medicinal Products Consumption Market Share by Country (2021-2032) Figure 54. China Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. Japan Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. South Korea Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. Southeast Asia Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 58. India Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. Australia Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. South America Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. South America Similar Biological Medicinal Products Consumption Market Share by Country (2021-2032) Figure 62. Brazil Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. Argentina Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 64. Chile Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 65. Middle East & Africa Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 66. Middle East & Africa Similar Biological Medicinal Products Consumption Market Share by Country (2021-2032) Figure 67. Egypt Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 68. South Africa Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 69. Israel Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 70. Türkiye Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 71. GCC Countries Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 72. Similar Biological Medicinal Products Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Similar Biological Medicinal Products Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Anti-inflammatory Drugs
  • Immunomodulator
  • Recombinant Hormone
  • Others
Applications
  • Oncology
  • Blood Disorders
  • Growth Hormone Deficiency
  • Chronic and Autoimmune Diseases
  • Others
Companies covered
  • CITIC Guojian
  • Changchun High-tech
  • Innovent Biologics
  • Saijin Biotechnology
  • Fuhong Hanlin
  • Baitai Biology
  • Biotech
  • Sandoz
  • Samsung Bioepies Co., Ltd
  • Amgen
  • Celltrion Healthcare
  • Coherus Biosciences, Inc.
  • Eli Lilly
  • Novartis AG
  • Pfizer Inc
  • Stada Arzneimittel AG
  • Teva Pharmaceutical Industries Ltd
  • Viatris

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Similar Biological Medicinal Products Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Similar Biological Medicinal Products Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Similar Biological Medicinal Products Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Similar Biological Medicinal Products Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Similar Biological Medicinal Products Market Dynamics
  1. 2.1 Similar Biological Medicinal Products Industry Trends
  2. 2.2 Similar Biological Medicinal Products Industry Drivers
  3. 2.3 Similar Biological Medicinal Products Industry Opportunities and Challenges
  4. 2.4 Similar Biological Medicinal Products Industry Restraints
3 Similar Biological Medicinal Products Market by Manufacturers
  1. 3.1 Global Similar Biological Medicinal Products Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Similar Biological Medicinal Products Production by Manufacturers (2021-2026)
  3. 3.3 Global Similar Biological Medicinal Products Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Similar Biological Medicinal Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Similar Biological Medicinal Products Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Similar Biological Medicinal Products Manufacturers, Product Type & Application
  7. 3.7 Global Similar Biological Medicinal Products Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Similar Biological Medicinal Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Similar Biological Medicinal Products Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Similar Biological Medicinal Products Tier 1, Tier 2, and Tier 3
4 Similar Biological Medicinal Products Market by Type
  1. 4.1 Similar Biological Medicinal Products Type Introduction
  2. 4.1.1 Monoclonal Antibodies
  3. 4.1.2 Anti-inflammatory Drugs
  4. 4.1.3 Immunomodulator
  5. 4.1.4 Recombinant Hormone
  6. 4.1.5 Others
  7. 4.2 Global Similar Biological Medicinal Products Production by Type
  8. 4.2.1 Global Similar Biological Medicinal Products Production by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Similar Biological Medicinal Products Production by Type (2021-2032)
  10. 4.2.3 Global Similar Biological Medicinal Products Production Market Share by Type (2021-2032)
  11. 4.3 Global Similar Biological Medicinal Products Production Value by Type
  12. 4.3.1 Global Similar Biological Medicinal Products Production Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Similar Biological Medicinal Products Production Value by Type (2021-2032)
  14. 4.3.3 Global Similar Biological Medicinal Products Production Value Market Share by Type (2021-2032)
5 Similar Biological Medicinal Products Market by Application
  1. 5.1 Similar Biological Medicinal Products Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Blood Disorders
  4. 5.1.3 Growth Hormone Deficiency
  5. 5.1.4 Chronic and Autoimmune Diseases
  6. 5.1.5 Others
  7. 5.2 Global Similar Biological Medicinal Products Production by Application
  8. 5.2.1 Global Similar Biological Medicinal Products Production by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Similar Biological Medicinal Products Production by Application (2021-2032)
  10. 5.2.3 Global Similar Biological Medicinal Products Production Market Share by Application (2021-2032)
  11. 5.3 Global Similar Biological Medicinal Products Production Value by Application
  12. 5.3.1 Global Similar Biological Medicinal Products Production Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Similar Biological Medicinal Products Production Value by Application (2021-2032)
  14. 5.3.3 Global Similar Biological Medicinal Products Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 CITIC Guojian
  2. 6.1.1 CITIC Guojian Company Information
  3. 6.1.2 CITIC Guojian Business Overview
  4. 6.1.3 CITIC Guojian Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 CITIC Guojian Similar Biological Medicinal Products Product Portfolio
  6. 6.1.5 CITIC Guojian Recent Developments
  7. 6.2 Changchun High-tech
  8. 6.2.1 Changchun High-tech Company Information
  9. 6.2.2 Changchun High-tech Business Overview
  10. 6.2.3 Changchun High-tech Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Changchun High-tech Similar Biological Medicinal Products Product Portfolio
  12. 6.2.5 Changchun High-tech Recent Developments
  13. 6.3 Innovent Biologics
  14. 6.3.1 Innovent Biologics Company Information
  15. 6.3.2 Innovent Biologics Business Overview
  16. 6.3.3 Innovent Biologics Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Innovent Biologics Similar Biological Medicinal Products Product Portfolio
  18. 6.3.5 Innovent Biologics Recent Developments
  19. 6.4 Saijin Biotechnology
  20. 6.4.1 Saijin Biotechnology Company Information
  21. 6.4.2 Saijin Biotechnology Business Overview
  22. 6.4.3 Saijin Biotechnology Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Saijin Biotechnology Similar Biological Medicinal Products Product Portfolio
  24. 6.4.5 Saijin Biotechnology Recent Developments
  25. 6.5 Fuhong Hanlin
  26. 6.5.1 Fuhong Hanlin Company Information
  27. 6.5.2 Fuhong Hanlin Business Overview
  28. 6.5.3 Fuhong Hanlin Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Fuhong Hanlin Similar Biological Medicinal Products Product Portfolio
  30. 6.5.5 Fuhong Hanlin Recent Developments
  31. 6.6 Baitai Biology
  32. 6.6.1 Baitai Biology Company Information
  33. 6.6.2 Baitai Biology Business Overview
  34. 6.6.3 Baitai Biology Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Baitai Biology Similar Biological Medicinal Products Product Portfolio
  36. 6.6.5 Baitai Biology Recent Developments
  37. 6.7 Biotech
  38. 6.7.1 Biotech Company Information
  39. 6.7.2 Biotech Business Overview
  40. 6.7.3 Biotech Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Biotech Similar Biological Medicinal Products Product Portfolio
  42. 6.7.5 Biotech Recent Developments
  43. 6.8 Sandoz
  44. 6.8.1 Sandoz Company Information
  45. 6.8.2 Sandoz Business Overview
  46. 6.8.3 Sandoz Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Sandoz Similar Biological Medicinal Products Product Portfolio
  48. 6.8.5 Sandoz Recent Developments
  49. 6.9 Samsung Bioepies Co., Ltd
  50. 6.9.1 Samsung Bioepies Co., Ltd Company Information
  51. 6.9.2 Samsung Bioepies Co., Ltd Business Overview
  52. 6.9.3 Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Product Portfolio
  54. 6.9.5 Samsung Bioepies Co., Ltd Recent Developments
  55. 6.10 Amgen
  56. 6.10.1 Amgen Company Information
  57. 6.10.2 Amgen Business Overview
  58. 6.10.3 Amgen Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Amgen Similar Biological Medicinal Products Product Portfolio
  60. 6.10.5 Amgen Recent Developments
  61. 6.11 Celltrion Healthcare
  62. 6.11.1 Celltrion Healthcare Company Information
  63. 6.11.2 Celltrion Healthcare Business Overview
  64. 6.11.3 Celltrion Healthcare Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 Celltrion Healthcare Similar Biological Medicinal Products Product Portfolio
  66. 6.11.5 Celltrion Healthcare Recent Developments
  67. 6.12 Coherus Biosciences, Inc.
  68. 6.12.1 Coherus Biosciences, Inc. Company Information
  69. 6.12.2 Coherus Biosciences, Inc. Business Overview
  70. 6.12.3 Coherus Biosciences, Inc. Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  71. 6.12.4 Coherus Biosciences, Inc. Similar Biological Medicinal Products Product Portfolio
  72. 6.12.5 Coherus Biosciences, Inc. Recent Developments
  73. 6.13 Eli Lilly
  74. 6.13.1 Eli Lilly Company Information
  75. 6.13.2 Eli Lilly Business Overview
  76. 6.13.3 Eli Lilly Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  77. 6.13.4 Eli Lilly Similar Biological Medicinal Products Product Portfolio
  78. 6.13.5 Eli Lilly Recent Developments
  79. 6.14 Novartis AG
  80. 6.14.1 Novartis AG Company Information
  81. 6.14.2 Novartis AG Business Overview
  82. 6.14.3 Novartis AG Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  83. 6.14.4 Novartis AG Similar Biological Medicinal Products Product Portfolio
  84. 6.14.5 Novartis AG Recent Developments
  85. 6.15 Pfizer Inc
  86. 6.15.1 Pfizer Inc Company Information
  87. 6.15.2 Pfizer Inc Business Overview
  88. 6.15.3 Pfizer Inc Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  89. 6.15.4 Pfizer Inc Similar Biological Medicinal Products Product Portfolio
  90. 6.15.5 Pfizer Inc Recent Developments
  91. 6.16 Stada Arzneimittel AG
  92. 6.16.1 Stada Arzneimittel AG Company Information
  93. 6.16.2 Stada Arzneimittel AG Business Overview
  94. 6.16.3 Stada Arzneimittel AG Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  95. 6.16.4 Stada Arzneimittel AG Similar Biological Medicinal Products Product Portfolio
  96. 6.16.5 Stada Arzneimittel AG Recent Developments
  97. 6.17 Teva Pharmaceutical Industries Ltd
  98. 6.17.1 Teva Pharmaceutical Industries Ltd Company Information
  99. 6.17.2 Teva Pharmaceutical Industries Ltd Business Overview
  100. 6.17.3 Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  101. 6.17.4 Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Product Portfolio
  102. 6.17.5 Teva Pharmaceutical Industries Ltd Recent Developments
  103. 6.18 Viatris
  104. 6.18.1 Viatris Company Information
  105. 6.18.2 Viatris Business Overview
  106. 6.18.3 Viatris Similar Biological Medicinal Products Production, Value and Gross Margin (2021-2026)
  107. 6.18.4 Viatris Similar Biological Medicinal Products Product Portfolio
  108. 6.18.5 Viatris Recent Developments
7 Global Similar Biological Medicinal Products Production by Region
  1. 7.1 Global Similar Biological Medicinal Products Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Similar Biological Medicinal Products Production by Region (2021-2032)
  3. 7.2.1 Global Similar Biological Medicinal Products Production by Region (2021-2026)
  4. 7.2.2 Global Similar Biological Medicinal Products Production Forecast by Region (2027-2032)
  5. 7.3 Global Similar Biological Medicinal Products Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Similar Biological Medicinal Products Production Value by Region (2021-2032)
  7. 7.4.1 Global Similar Biological Medicinal Products Production Value by Region (2021-2026)
  8. 7.4.2 Global Similar Biological Medicinal Products Production Value by Region (2027-2032)
  9. 7.5 Global Similar Biological Medicinal Products Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Similar Biological Medicinal Products Production Value (2021-2032)
  12. 7.6.2 Europe Similar Biological Medicinal Products Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Similar Biological Medicinal Products Production Value (2021-2032)
  14. 7.6.4 South America Similar Biological Medicinal Products Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Similar Biological Medicinal Products Production Value (2021-2032)
8 Global Similar Biological Medicinal Products Consumption by Region
  1. 8.1 Global Similar Biological Medicinal Products Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Similar Biological Medicinal Products Consumption by Region (2021-2032)
  3. 8.2.1 Global Similar Biological Medicinal Products Consumption by Region (2021-2026)
  4. 8.2.2 Global Similar Biological Medicinal Products Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Similar Biological Medicinal Products Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Similar Biological Medicinal Products Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Similar Biological Medicinal Products Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Similar Biological Medicinal Products Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Similar Biological Medicinal Products Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Similar Biological Medicinal Products Value Chain Analysis
  2. 9.1.1 Similar Biological Medicinal Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Similar Biological Medicinal Products Production Mode & Process
  6. 9.2 Similar Biological Medicinal Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Similar Biological Medicinal Products Distributors
  9. 9.2.3 Similar Biological Medicinal Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst